Blocking tumor-educated MSC paracrine activity halts osteosarcoma progression SR Baglio, T Lagerweij, M Pérez-Lanzón, XD Ho, N Léveillé, SA Melo, ... Clinical Cancer Research 23 (14), 3721-3733, 2017 | 171 | 2017 |
Whole transcriptome analysis identifies differentially regulated networks between osteosarcoma and normal bone samples XD Ho, P Phung, V Q Le, V H Nguyen, E Reimann, E Prans, G Koks, ... Experimental Biology and Medicine 242 (18), 1802-1811, 2017 | 83 | 2017 |
Whole exome sequencing of a single osteosarcoma case—integrative analysis with whole transcriptome RNA-seq data E Reimann, S Kõks, XD Ho, K Maasalu, A Märtson Human Genomics 8, 1-16, 2014 | 66 | 2014 |
The genetic legacy of continental scale admixture in Indian Austroasiatic speakers K Tätte, L Pagani, AK Pathak, S Kõks, B Ho Duy, XD Ho, GNN Sultana, ... Scientific reports 9 (1), 3818, 2019 | 49 | 2019 |
Analysis of the expression of repetitive DNA elements in osteosarcoma XD Ho, HG Nguyen, LH Trinh, E Reimann, E Prans, G Kõks, K Maasalu, ... Frontiers in genetics 8, 193, 2017 | 45 | 2017 |
Upregulation of 15 antisense long non-coding RNAs in osteosarcoma E Rothzerg, XD Ho, J Xu, D Wood, A Märtson, S Kõks Genes 12 (8), 1132, 2021 | 33 | 2021 |
Alternative splicing of leptin receptor overlapping transcript in osteosarcoma E Rothzerg, XD Ho, J Xu, D Wood, A Märtson, K Maasalu, S Kõks Experimental Biology and Medicine 245 (16), 1437-1443, 2020 | 15 | 2020 |
Cross-sectional study to characterise nicotine dependence in central Vietnamese men G Kõks, HDT Tran, NBT Ngo, LNN Hoang, HMT Tran, TC Ngoc, TD Phuoc, ... Substance abuse: research and treatment 13, 1178221818822979, 2019 | 11 | 2019 |
Genetic interaction between two VNTRs in the MAOA gene is associated with the nicotine dependence G Kõks, E Prans, XD Ho, BH Duy, HDT Tran, NBT Ngo, LNN Hoang, ... Experimental Biology and Medicine 245 (8), 733-739, 2020 | 10 | 2020 |
Genetic interaction between two VNTRs in the SLC6A4 gene regulates nicotine dependence in Vietnamese men G Kõks, E Prans, HDT Tran, NBT Ngo, LNN Hoang, HMT Tran, ... Frontiers in Pharmacology 9, 1398, 2018 | 8 | 2018 |
Characterization of the genomic profile of osteosarcoma XD Ho Tartu, 2018 | 8 | 2018 |
Q Le V, H Nguyen V, Reimann E, Prans E, et al. Whole transcriptome analysis identifies differentially regulated networks between osteosarcoma and normal bone samples XD Ho, P Phung Exp Biol Med (Maywood) 242 (18), 1802-11, 2017 | 6 | 2017 |
Outcome of HER2-positive breast cancer patients following metastatic relapse after adjuvant trastuzumab treatment since EMA regulatory approval. JP Spano, S Vignot, XD Ho, N Zongo, C Magneux, C Genestie, ... Journal of Clinical Oncology 30 (15_suppl), 641-641, 2012 | 4 | 2012 |
Primary invasive ductal carcinoma of axillary accessory breast TH Nguyen, E El-Helou, CF Pop, A Shall, M Zaiter, J Naccour, XD Ho, ... International Journal of Surgery Case Reports 98, 107597, 2022 | 3 | 2022 |
Primary breast Tuberculosis Mastitis manifested as nonhealing abscess H Hoang, E El-Helou, CF Pop, A Shall, M Zaiter, J Naccour, TTH Nguyen, ... The Surgery Journal 8 (02), e123-e126, 2022 | 3 | 2022 |
Whole transcriptome analysis of osteosarcoma S Koks, E Reimann, K Maasalu, G Koks, DH Xuan, E Prans, A Martson The FASEB Journal 30, 515.6-515.6, 2016 | 3 | 2016 |
Direct medical cost of adjuvant systemic treatment for HER2-positive breast cancer in Vietnam TNN Luu, HTT Ngo, XD Ho, QDT Phan, TV Truong, LH Nguyen, ... Journal of Pharmacy & Pharmacognosy Research 13 (1), 264-273, 2025 | | 2025 |
Hoang-Quy Nguyen1, Khanh-Luan Tran2, Manh-Hung Vuong3 QT Tran, XD Ho Treatment Landscape of Targeted Therapies in Oncology: Challenges and …, 2023 | | 2023 |
Colorectal cancer heterogeneity and targeted therapy: clinical implications, challenges, and solutions for treatment resistance HQ Nguyen, KL Tran, MH Vuong, QT Tran, XD Ho Treatment Landscape of Targeted Therapies in Oncology, 207-221, 2023 | | 2023 |
Targeted therapy and drug resistance in gastric and pancreatic cancer XD Ho, MH Vuong, KL Tran, HQ Nguyen, QT Tran Treatment Landscape of Targeted Therapies in Oncology, 183-206, 2023 | | 2023 |